Atlanta, GA, United States of America

Efstathios Karathanasis


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Efstathios Karathanasis: Innovator in Nano-scale Contrast Agents

Introduction

Efstathios Karathanasis is a prominent inventor based in Atlanta, GA (US). He has made significant contributions to the field of medical imaging and therapeutics, particularly through his innovative work on nano-scale contrast agents. With a total of 3 patents, his inventions are paving the way for advancements in cancer treatment and diagnostics.

Latest Patents

Karathanasis's latest patents focus on the development of nano-scale contrast agents and their methods of use. These compositions and methods are designed for evaluating a subject's vasculature integrity, differentiating between malignant and benign lesions, and assessing the accessibility of tumors to nano-sized therapeutics. His work also includes techniques for treating tumors and enabling live or real-time monitoring of a nano-probe's biodistribution.

Career Highlights

Throughout his career, Efstathios Karathanasis has worked with various companies, including Marval Pharma, Inc. His expertise in the field has allowed him to contribute to groundbreaking research and development in medical technologies. His innovative approach has garnered attention and respect within the scientific community.

Collaborations

Karathanasis has collaborated with notable professionals in his field, including Ananth V Annapragada and Ravi Bellamkonda. These collaborations have further enhanced his research and development efforts, leading to significant advancements in the application of nano-scale technologies in medicine.

Conclusion

Efstathios Karathanasis is a key figure in the innovation of nano-scale contrast agents, with a focus on improving cancer diagnostics and treatment. His contributions are vital to the ongoing evolution of medical imaging technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…